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Cervical cancer and breast cancer are leading causes of cancer-related morbidity and 
mortality in Costa Rica. This article reports results of an evaluation of cervical and 
breast cancer screening practices among Costa Rican women 25 to 58 years old that 
was based on a nationwide 1984-1985 survey. The evaluation showed that while 
Pap smears were widely used to screen for cervical cancer, many women did not 
have their first cervical smear or gynecologic examination until age 30, and that 
cervical cancer screening was less common among certain high-risk groups, includ-
ing women with multiple sexual partners and those with high parity. Less than half 
the women surveyed reported having had a breast examination by a health care 
provider. Utilization of both cervical cancer and breast cancer screening examina-
tions could be increased by targeting inadequately screened high-risk women 
through the existing health care system. 
Gynecologic cancer has become an in-creasingly important health prob-
lem in Costa Rica and many other Latin 
American countries (1, 2). Specifically, 
Costa Rica reports one of the highest inci-
dence rates of cervical cancer in the 
world, and cervical cancer is the second 
leading cause of cancer mortality among 
Costa Rican women. In 1984, 18 Costa 
Rican women per 100,000 over 19 years of 
age died of this disease (3). 
Conversely, the annual incidence of 
breast cancer in Costa Rica is less than 
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half that found in the United States. 
However, mortality from this disease has 
been increasing gradually, to a point 
where in 1984 it caused 16 deaths per 
100,000 Costa Rican women over 19 years 
of age (3, 4). 
Cervical and breast cancer are among 
the few cancers for which screening or 
early-detection tests are available. In 
Costa Rica, screening services are provided 
through an extensive system of Govern-
ment-sponsored clinics, rural health 
workers who encourage referrals to these 
clinics, and, for a minority of women, 
private-sector clinicians (5). Cervical 
smears and pelvic examinations have 
been offered extensively since the late 
1960s, largely in conjunction with family 
planning services. Breast examinations 
provided by doctors or nurses have been 
widely available throughout Costa Rica, 
and self-examination has been promoted 
recently through educational campaigns. 
However, access to mammography con-
tinues to be very limited (6). 
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METHODS 
To determine the extent and potential 
benefits of screening for cervical and 
breast cancer in Costa Rica, we analyzed 
data from a population-based, case-con-
trol study of these cancers that had been 
conducted in 1984. The methods em-
ployed in that study have previously 
been reported in detail (7-11). 
The analysis presented here had two 
components: a descriptive analysis of the 
control women included in the study and 
a case-control analysis of invasive cervi-
cal cancer cases and controls. We re-
stricted the descriptive analysis to the 
control group because the women in that 
group constituted a sample representa-
tive of women 25-58 years old nation-
wide, one that would reflect the cancer 
screening practices among the general 
population. 
These control women had been identi-
fied through a household survey con-
ducted between September 1984 and 
February 1985. Their selection through 
probability sampling was based on a 
multistage, cluster-sample methodology 
that used a sampling frame from the June 
1984 census. Certain age groups were 
oversampled so that the age distribution 
of the control women would match that 
of the combined group of cervical and 
breast cancer cases in the case-control 
study. In the descriptive analysis the re-
sults were weighted for age to compen-
sate for this oversampling and reflect the 
actual age distribution of Costa Rican 
women 25 to 58 years old (12). 
During the household survey, trained 
interviewers questioned women in their 
homes about demographic characteris-
tics, reproductive and contraceptive his-
tories, risk factors for cervical and breast 
cancer, and history of screening examina-
tions. Of the 938 women eligible for in-
clusion as controls, 861 (91.8%) between  
the ages of 25 and 58 completed an 
interview. 
We evaluated the following aspects of 
the controls' cervical cancer screening 
histories: their history of cervical smears 
or gynecologic examinations completed 
before the interview and before 1982 
(when the cancer case enrollment period 
began), the year of their first smear or 
examination and their age at that time, 
the interval between the interview and 
the last smear or examination, and the 
number of cervical smears before 1982. 
Although we collected information on 
cervical smears and gynecologic exam-
inations separately, we combined this in-
formation to obtain a single measure of 
cervical cancer screening. In Costa Rica, 
the pelvic examination usually includes a 
cervical smear, although a woman may 
not know such a smear has been taken. 
We also evaluated two methods for 
early detection of breast cancer: the num-
ber of breast examinations performed by 
a doctor or nurse before 1982 and the fre-
quency of breast self-examinations con-
ducted by the subject before 1982. We 
did not collect any information on 
mammography. 
For the case-control analysis, we esti-
mated the degree of protection against 
invasive cervical cancer that screening 
provided. This was done using methods 
reported elsewhere—by calculating odds 
ratios (estimates of relative risk) associ-
ated with biopsy-confirmed invasive cer-
vical cancer (7-9). Overall, we compared 
the screening histories of 149 invasive 
cervical cancer cases and 764 controls 
who did not have cervical disease before 
the reference date. (For cases, the refer-
ence date was the date of diagnosis; for 
controls it was 15 February 1983, the mid-
point of the case enrollment period.) 
Women who had undergone a hysterec-
tomy or conization of the cervix were ex-
cluded from the control group. Although 
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the study included cases of carcinoma in 
situ, these were excluded from the pre-
sent analysis because most carcinoma in 
situ cases are asymptomatic and are de-
tected only as a result of a cervical smear; 
thus, in most women a history of cervical 
smears would be directly linked to 
diagnosis. 
Using logistic regression (13), odds ra-
tios were adjusted simultaneously for the 
following confounding factors: age, so-
cioeconomic status, region of residence, 
number of lifetime sexual partners, and 
use of oral contraceptives at any time. For 
each analysis, women lacking the par-
ticular screening history served as the 
reference group. Tests for linear trends 
(13) among women with the particular 
screening history in question were per-
formed using three factors as continuous 
variables-the number of smears, the 
subjects' age (in years) at the time of the 
first smear, and the number of months 
elapsed since the last smear. We did not 
evaluate the effect of early-detection pro-
cedures for breast cancer because we did 
not collect information on the stage of the 
cancer at diagnosis or mortality. 
RESULTS 
Cervical Cancer Screening Practices 
Most of the control women (83.5%) re-
ported having had a cervical smear or gy-
necologic examination before the inter-
view; fewer (74.7%) specifically reported 
having a smear taken before 1982 (Table 
1). About half (51.3%) of those reporting 
a smear or examination had one of these 
done within a year before interview. 
The proportion of women whose first 
cervical smear was taken by age 30 was 
greater among younger women than 
older women, which reflects the in-
creased availability of this test in the 
1970s. Of those controls 25 to 58 years old 
who reported a smear or gynecologic 
Table 1. History of cervical smears or 
gynecologic examinations in control women 
25-58 years old. 
History 
Had at least one smear or examination 
before interviews 	 83.5 
Had smear before 1982a 	 74.7 
Interval since last smear or examinationb 
<1 year 	 51.3 
1-2 years 	 21.2 
3-4 years 	 16.2 
5-9 years 	 6.9 
>10 years 	 3.7 
Unknown 	 0.7 
Age at first smear or examination:' 
<20 years 
	 12.9 
20-24 years 	 30.3 
25-29 years 
	
22.2 
30-39 years 
	 19.0 
40-49 years 
	 12.9 
50+ years 	 2.7 
Age at first smear or examination (among 
women 25-34 years old):,' 
<20 years 
	
23.2 
20-24 years 
	
46.5 
25-29 years 	 24.8 
30-34 years 
	
5.5 
'Percentage of all women (N = 861); weighted for age 
'Percentage of all women who had smear or exam (N = 
711); weighted for age 
`Percentage of all women 25-34 years old who had smear 
or exam (N -= 249); weighted for age. 
exam, the mean age at the first smear or 
exam was 30.4 years (standard deviation 
of 9.9 years); 56.8% reported having their 
first smear or examination after age 24, 
and 34.6% after age 29. By comparison, 
among the controls 25 to 34 years old, a 
group that would have had greater access 
to cervical smears in their teens and 
twenties, the mean age at their first 
smear or exam was 22.8 years (standard 
deviation of 4.0 years), while only 30.3% 
reported having had their first smear or 
examination after age 24. 
In all, 612 of the controls reported hav-
ing a smear taken before 1982. However, 
the data in Table 2 show that those 30 to 
49 years old were more likely to have had 
a smear than younger or older women. 
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Table 2. Control women 25-58 years old who had at least one cervical smear before 1982, by 
selected characteristics. 
Characteristic %a Characteristic 
Age: No. of lifetime sexual partners: 
25-29 years 67.7 None 28.1 
30-39 years 80.6 1 78.4 
40-49 years 76.8 2-4 77.7 
50+ years 68.6 a-5 58.1 
Marital status: No. of pregnancies: 
Currently married 80.8 None 36.1 
Divorced, separated, or widowed 73.2 1-2 75.0 
Single 50.6 3-9 83.4 
10 59.9 
Residence: 
San Jose 82.5 History of any sexually transmitted 
Central valley 73.5 disease: 
Other urban 78.4 Yes 84.4 
Other rural 62.1 No 73.3 
Socioeconomic status: 
Low 
Medium 
67.2 
75.7 
Treated for any sexually transmitted 
disease: 
High 86.8 Yes 83.5 
No 73.6 
Years of education: 
None 54.5 Have used oral contraceptives: 
1-6 years 76.1 Yes 90.1 
7 years 77.0 No 58.5 
Unknown 82.3 
Age at first sexual intercourse: 
<20 years 80.0 Have received tetanus vaccine: 
20-24 years 78.5 Yes 76.4 
25 years 67.7 No 62.5 
Never had sexual intercourse 28.1 Unknown 73.9 
Smoking history: 
Never smoked 72.6 
Current smoker 83.4 
Former smoker 78.7 
'Percentage of women in a given group who had at least one smear taken; weighted for age (N = 861). 
Similarly, women who were currently 
married, lived in the capital of San Jose, 
had the highest socioeconomic status, 
and had some formal education were 
relatively more likely to have been 
screened at some time before 1982. A his-
tory of having been screened was also 
more common among women who first 
had intercourse before age 20, who had 
one to four sexual partners (as compared 
with no partners or five or more part-
ners), who were pregnant one to nine 
times (as compared to no times or 10 or  
more times), and who had a history of 
any sexually transmitted disease (STD) or 
reported treatment for any STD. 
Screening was also more common 
among women who had undergone hys-
terectomy or tubal sterilization and 
among those who had used oral contra-
ceptives and other modern contracep-
tives (including injectable hormones, in-
trauterine devices, diaphragms, spermi-
cides, or condoms). In addition, women 
who had received tetanus vaccine, who 
reported being current smokers, who 
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ever douched, who had undergone a 
breast examination by a doctor or nurse, 
or who practiced breast self-examination 
were more likely to have been screened 
for cervical cancer than other control 
women. However, the controls' histories 
indicated no appreciable screening prev-
alence differences among those who had 
received rubella vaccine, who had been 
diagnosed as infertile by a physician, or 
who had a family history of cervical 
cancer. 
Women who had at least one cervical 
smear taken before 1982 experienced 
about one-half the risk of invasive cervi- 
cal cancer of women who had none (Ta-
ble 3). There was no clear pattern of in-
creasing or decreasing risk with the 
number of smears or the subject's age at 
first smear. However, women who had 
their last cervical smear less than one 
year before the reference date had a sig-
nificantly elevated risk of cervical cancer, 
and the level of risk decreased signifi-
cantly as the time elapsed since the last 
examination increased. In a separate 
analysis, we excluded women who had 
their last cervical smear during the year 
before their reference date. In this group, 
the overall risk of cervical cancer associ- 
Table 3. Relative risk of invasive cervical cancer associated with a history of at 
least one cervical smear or gynecologic exam. 
History 
Cases 
(N=136),  
Controls 
(N=700),  
Adjusted 
RR (95 0/. Cl)b 
Never had smear (referent) 52 174 1.0 
Had smear before 1982 84 526 0.6 (0.4-1.0) 
No. of smears: 
1 smear 9 103 0.3 (0.2-0.7) 
2-4 smears 33 169 0.8 (0.5-1.4) 
5-9 smears 11 117 0.5 (0.2-1.0) 
10 smears 19 96 1.0 (0.5-2.0) 
Unknown number of smears 12 41 
Test for trend: p = 0.2 
Age at first smear or gynecologic 
examination: 
<20 years 12 46 2.0 (0.8-4.8) 
20-29 years 27 248 0.7 (0.4-1.2) 
30-39 years 17 98 0.6 (0.3-1.1) 
40 years 16 93 0.5 (0.2-1.0) 
Unknown age 12 41 
Test for trend: p = 0.5 
Interval between last smear and reference 
date: 
1-11 months 12 40 4.7 (1.6-13.8) 
12-23 months 4 24 2.7 (0.7-10.7) 
24-59 months 2 47 0.5 (0.1-2.6) 
60 months 1 39 0.4 (0.1-3.0) 
Had last smear after reference date 53 335 
Unknown interval 12 41 
Test for trend: p = 0.009 
'Thirteen cases and 64 controls with unknown values for adjustment factors have been excluded from 
the frequency tables. 
bAdjusted for age, socioeconomic status, residence, history of oral contraceptive use, and number of 
lifetime sexual partners. Women who never had had a smear served as a reference group for all analyses. 
Among women who had at least one smear taken before 1982. 
20 	 Bulletin of PAHO 25(1), 1991 
ated with ever having had a smear (rela-
tive to those who never had a smear) was 
lowered from 0.6 to 0.2 (95% confidence 
interval 0.1-0.4). 
Breast Cancer Screening Practices 
Less than half (48.1%) of the 861 Costa 
Rican women 25 to 58 years old in the 
control group reported having had a 
breast examination performed by a doc-
tor or nurse (Table 4). Among women 
who reported having had at least one 
such examination, the vast majority had 
undergone less than five examinations 
before 1982. 
As the data in Table 5 indicate, groups 
of controls more likely to have had an 
examination by a doctor or nurse in-
cluded those between 30 and 49 years 
old, those who were or had been mar-
ried, those residing in San Jose, those 
with a relatively high socioeconomic sta-
tus, and those with some formal educa-
tion. Provider examinations were also 
more common among women who had 
Table 4. History of doctor- or nurse-provided 
breast examination and breast self-examination 
before 1982 among control women 25-58 
years old. 
History 	 %a 
No. of examinations 
provided by doctor or 
nurse: 
None 	 51.9 
1 or more 	 48.1 
1 
	
15.2 
2-4 	 19.6 
5-9 	 6.9 
..›...- 10 
	
6.1 
Unknown 	 0.3 
Frequency of self- 
examination: 
Never 	 58.3 
At least once 	 41.7 
Frequently 	 16.1 
Occasionally 	 25.6 
'Percentage of all women (N = 861); weighted for age. 
one to nine pregnancies (as compared to 
no pregnancies or 10 or more), who were 
surgically postmenopausal (as compared 
with premenopausal or naturally meno-
pausal), who had previously undergone 
a hysterectomy, who had a history of 
physician-diagnosed infertility, who 
used oral contraceptives and other mod-
ern contraceptives (including injectable 
hormones, intrauterine devices, barrier 
methods, or tubal sterilization), who had 
received rubella vaccine, and who had a 
family history of breast cancer. 
Women who had practiced self-exam-
ination were also more likely to have had 
a provider examination. No appreciable 
differences in the prevalence of provider 
examinations were observed in groups 
who had a history of or who had been 
treated for diabetes, hypertension, or 
STD, who had received tetanus vaccine, 
or who had ever smoked. 
Less than half (41.7%) of the women in 
the control group had performed self-ex-
amination of their breasts before 1982 
(see Table 4), and of these less than half 
(38.2%) had done so frequently. As indi-
cated in Table 5, self-examination was 
more common among women 30 to 49 
years old than among younger or older 
women. Characteristics of women who 
performed self-examinations were gener-
ally similar to those of women who re-
ceived provider examinations, with the 
exception that women with physician-di-
agnosed infertility were less likely to 
have examined their breasts. 
DISCUSSION 
Cervical Cancer Screening 
Screening for cervical cancer is fairly 
widespread in Costa Rica. We found that 
about 83% of the controls 25 to 58 years 
old had had at least one cervical smear. 
This prevalence of cervical cancer screen-
ing was somewhat greater than the 
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Table 5. Control women 25-58 years old who had breast ex-
aminations before 1982, by selected characteristics. 
% who had 
Characteristic 	 provider examinations. 
% who 
performed self- 
examinations. 
Age: 
25-29 years 39.8 38.3 
30-39 years 56.2 45.4 
40-49 years 51.3 44.8 
50 years 37.1 34.5 
Marital status: 
Married 51.6 41.5 
Divorced or separated 50.0 45.2 
Widowed 24.5 37.9 
Single 36.3 41.9 
Residence: 
San Jose 57.9 45.7 
Central valley 48.5 40.5 
Other urban 45.4 44.1 
Other rural 33.0 36.6 
Socioeconomic status: 
Low 34.9 33.5 
Medium 53.9 45.3 
High 65.1 53.0 
Years of education: 
None 21.0 26.7 
1-6 years 44.5 38.9 
7 years 59.5 49.6 
Number of pregnancies: 
None 35.2 35.1 
1-2 51.9 46.0 
3-4 53.3 40.2 
5-9 49.1 45.1 
10 28.3 34.6 
Menopausal status: 
Premenopausal 49.0 42.3 
Postmenopausal 
(natural) 38.9 34.4 
Postmenopausal 
(surgical) 58.1 55.1 
History of hysterectomy: 
Yes 54.2 55.7 
No 47.5 40.8 
Physician-diagnosed 
female infertility: 
Yes 71.3 40.3 
No 47.3 41.7 
Have used oral contraceptives: 
Yes 53.1 43.8 
No 43.4 39.5 
Unknown 46.7 43.2 
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Table 5. Continued. 
Characteristic 
% who had 
provider examinations• 
0/0 who 
performed self- 
examinations• 
Have received rubella 
vaccine: 
Yes 51.3 47.3 
No 43.6 37.3 
Unknown 47.5 36.8 
Family history of breast 
cancer: 
Yes 59.4 59.4 
No • 48.2 41.3 
Unknown 33.1 37.5 
Have performed breast 
self-examination: 
Yes 58.2 
No 40.6 
Have received provider 
breast examination: 
Yes 50.8 
No 33.7 
'Percentage of women in any given group who ever had a provider exam or 
performed a self-exam; weighted for age (N =861). 
69.9% prevalence reported for Costa Ri-
can women 15 to 49 years old in 1986 (6), 
possibly because our control group in-
cluded a greater proportion of older 
women. 
However, this 83% prevalence is still 
substantially lower than the 93% preva-
lence found in 1985 for U.S. women 17 
years of age and older (14). Although 
most of the women in our study had 
been screened, more than half had their 
first smear taken after age 24, several 
years after their mean age of first inter-
course (20 years) and at the age when the 
incidence of carcinoma in situ, a precur-
sor of invasive cervical cancer, begins to 
peak (3). For many women, therefore, 
the first smear may have been done too 
late to detect the early, most readily treat-
able stages of this disease. 
It is noteworthy that the incidence of 
invasive cervical cancer in Costa Rica de-
clined during the late 1970s (3). Our 
study suggests that two factors may have  
contributed to this decline. First, women 
tended to be screened at a younger age 
during the 1970s; and second, screening 
became fairly common among certain 
groups of women at high risk for cervical 
cancer—such as those who began sexual 
activity at an early age and those who 
had contracted an STD (15). However, 
cervical cancer screening was reported 
less frequently by other women poten-
tially at high risk, such as those who had 
multiple sexual partners (15) or high par-
ity (16), and these women should be tar-
geted for future prevention efforts. 
Because having been screened for cer-
vical cancer was associated with hyster-
ectomy, tubal sterilization, treatment of 
STD, provider breast exams, use of pre-
scription contraceptives, and receipt of 
tetanus vaccination, it appears that wom-
en who used gynecologic, obstetric, and 
family planning services also availed 
themselves of cancer screening services. 
Providers of these services could expand 
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screening coverage by using simple risk 
assessment procedures to identify inade-
quately screened women and by increas-
ing the number and frequency of refer-
rals made by rural health workers. In 
addition, further research on the deter-
minants of screening behaviors is needed 
to explain why some women are not 
screened despite the availability of 
services. 
Our case-control analysis found that 
cervical smears provided important pro-
tection against development of invasive 
cervical cancer; women who were 
screened experienced roughly half the 
risk of those who were not. This finding 
is consistent with risk estimates reported 
by other case-control studies (17-19). 
However, all case-control studies must be 
interpreted cautiously because their de-
sign is of limited usefulness in evaluating 
the effect of screening on reducing cancer 
cases (20). 
Because we did not collect information 
on the date of the last normal smear, we 
could not exclude women whose inva-
sive cancer was detected directly as a 
consequence of a last smear which was 
abnormal, i.e., one that led directly to di-
agnosis. The inclusion of these women 
among the 84 subjects with cervical can-
cer who had smears taken (Table 3) 
biased the odds ratio toward unity, 
thereby underestimating the protective 
effect of routine screening. The risk esti-
mate of 0.2, which was based only on 
women who had their last smear more 
than one year before the reference date—
a test that was less likely to have led di-
rectly to diagnosis—is a more accurate es-
timate of the protective effect of routine 
screening. 
Conversely, the adjusted risk estimate 
of 4.7 for women who had their last 
smear taken during the year before the 
reference date (Table 3) overestimates the 
true risk. Many (335) control women who 
had their last smear shortly before their  
interview but after the common refe-
rence date (15 February 1983) were not 
included in the calculation. 
Although limitations of this nature pre-
vent us from estimating the magnitude of 
the protective effect in a completely unbi-
ased fashion, our data do suggest that 
screening provides some important de-
gree of protection against the develop-
ment of invasive cervical cancer. 
Impressive progress has been made 
over the last two decades in Costa Rica by 
increasing the availability of Pap smears 
to all women, especially those at high 
risk of developing cervical cancer. De-
spite these gains, however, cervical can-
cer incidence and mortality remain high. 
Both could be reduced further by contin-
ued progress toward the Government's 
goal of providing an annual cervical 
smear for all women of reproductive age 
(6). Improving the quality of smears is 
also critically important—as shown by re-
cent reports in the international literature 
citing the low sensitivity of smears (21). 
Finally, an obvious point must be empha-
sized—that the cervical smear by itself 
has no preventive value, and that women 
with abnormal smears must be appro-
priately followed, diagnosed, and treated. 
Breast Cancer Screening 
Regarding detection of breast cancer, 
much work remains to be done. As of 
1982, a majority of Costa Rican women 
had not received a provider breast exam-
ination. Similarly, a majority had not per-
formed breast self-examination. Nor is 
there any indication that this situation 
has changed in recent years; available 
data indicate that as of 1986 only about 
41.3% of Costa Rican women 30 to 49 
years old had ever practiced self-exam-
ination (6). This prevalence is far lower 
than that for U.S. women 17 years of age 
and older: 1985 data indicate that 73% of 
these U.S. women had practiced self-ex- 
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amination and 92% had received a pro-
vider examination (14). 
Both provider examinations and self-
examinations were more common among 
Costa Rican women in certain groups at 
high risk for breast cancer (e.g., those 
with relatively high socioeconomic sta-
tus, those naturally postmenopausal, 
those with a history of infertility, and 
those with a family history of breast can-
cer) (22). However, screening was rela-
tively uncommon among women who 
had reached their fiftieth birthday—the 
age when breast cancer incidence and 
mortality begin to rise dramatically (3). 
Nulliparous women, another high-risk 
group (22), were also less likely to have 
been screened than parous women, 
largely because nulliparous women in 
Costa Rica tend to be young. 
In the future, women who are not re-
ceiving breast examinations or perform-
ing self-examinations might be identified 
through existing obstetric, gynecologic, 
and family planning services—because 
these examinations appear linked to re-
ceipt of other medical services such as 
rubella vaccination, hysterectomy, pre-
scription contraceptives, and tubal steril-
ization. Innovative strategies are re-
quired to identify older women who do 
not routinely seek these services. The fact 
that women who receive provider exams 
tend to have characteristics similar to 
those who perform self-examinations 
(Table 5) suggests that providers could 
encourage women to perform breast self-
examinations by giving explicit instruc-
tion during clinic visits. 
Although it is likely that, as currently 
practiced, provider and self-examina-
tions allow for early detection of breast 
cancer in Costa Rica as in other countries 
(23), it is not clear that provider or self-
examinations, particularly when done in-
frequently or without the added benefit 
of mammography, would contribute to 
any substantial decline in breast cancer  
mortality. However, until further studies 
resolve this issue, it seems prudent to en- 
courage provider and self-examinations, 
and mammography when possible, par-
ticularly among older women at high 
risk. 
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